Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Chemotherapy|February 27, 2010
Effect of extracellular ATP on cisplatin-induced cytotoxicity in human ovarian carcinoma cellsAnand Rotte, Dirk Garmann, Irina Buss, et al.CPT: Pharmacometrics & Systems Pharmacology|March 12, 2026
Impact of Event-Related Treatment Modifications in Exposure-Response Analyses of Repeated Time-to-Event DataSebastiaan Camiel Goulooze, Nelleke Snelder, Thomas Eissing, et al.Bioconjugate Chemistry|November 18, 2004
Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugsAndré Warnecke, Iduna Fichtner, Dirk Garmann, et al.Journal of Clinical Pharmacology|September 13, 2018
An Integrated Population Pharmacokinetic Analysis to Characterize Levonorgestrel Pharmacokinetics After Different Administration RoutesIsabel Reinecke, Birte Hofmann, Emir Mesic, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 12, 2008
Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cellsDirk Garmann, André Warnecke, Ganna V Kalayda, et al.Clinical Pharmacokinetics|December 23, 2016
Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia AAnita Shah, Alexander Solms, Dirk Garmann, et al.Clinical Pharmacology and Therapeutics|January 16, 2024
Model-Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing RegimenPeter N Morcos, Jonathan Moss, Josh Veasy, et al.Haematologica|August 3, 2019
Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patientsJoão A Abrantes, Alexander Solms, Dirk Garmann, et al.Clinical Pharmacokinetics|September 6, 2023
Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling ApproachesHauke Ruehs, Alexander Solms, Matthias Frei, et al.CPT: Pharmacometrics & Systems Pharmacology|November 1, 2019
Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIIIJoão A Abrantes, Alexander Solms, Dirk Garmann, et al.Pageof 3